GPT and peripheral neuropathy: Other adverse events, including grade 3–4 leukopenia, neutropenia, increased alanine transaminase, increased aspartate aminotransferase, nausea, vomiting, peripheral neuropathy, diarrhea, and constipation, had no significant differences between the two groups (p > 0.05).